102. Tocilizumb did not Significantly Increase Serum Cholesterol Levels in Healthy Subjects
Auteur
Grange, Susan. Department of Clinical Pharmacology, F. Hoffmann-La Roche Ltd., Basel, SWITZERLAND, Department of Global Medical Affairs-Immunology, F. Hoffman-La Roche Ltd., Basel, SWITZERLAND, Institute of Infection and Immunity, Director of Arthritis Research UK CREATE Centre, Cardiff, UK
Schmitt, Christophe. Department of Clinical Pharmacology, F. Hoffmann-La Roche Ltd., Basel, SWITZERLAND, Department of Global Medical Affairs-Immunology, F. Hoffman-La Roche Ltd., Basel, SWITZERLAND, Institute of Infection and Immunity, Director of Arthritis Research UK CREATE Centre, Cardiff, UK
Ganeshalingam, Kandeepan. Department of Clinical Pharmacology, F. Hoffmann-La Roche Ltd., Basel, SWITZERLAND, Department of Global Medical Affairs-Immunology, F. Hoffman-La Roche Ltd., Basel, SWITZERLAND, Institute of Infection and Immunity, Director of Arthritis Research UK CREATE Centre, Cardiff, UK
Choy, Ernest H.. Department of Clinical Pharmacology, F. Hoffmann-La Roche Ltd., Basel, SWITZERLAND, Department of Global Medical Affairs-Immunology, F. Hoffman-La Roche Ltd., Basel, SWITZERLAND, Institute of Infection and Immunity, Director of Arthritis Research UK CREATE Centre, Cardiff, UK
Type de document
Postprint
Langue
Anglais
Publié dans
Rheumatology, 2014, vol. 53, p. i95-i96. Oxford University Press